1. Field of the Invention
The present invention is directed to intraocular lenses (IOLs) that define an optical power that is adjustable following implantation. More particularly, the IOL is adapted for use in cataract patients that require an adjustment in the optical power of the lens post-implantation.
2. Description of the Related Art
Cataracts are a major cause of blindness in the world and the most prevalent ocular disease. Visual disability from cataracts accounts for more than 8 million physician office visits per year. When the disability from cataracts affects or alters an individual's activities of daily living, surgical lens removal with intraocular lens implantation is the preferred method of treating the functional limitations. In the United States, about 2.5 million cataract surgical procedures are performed annually, making it the most common surgery for Americans over the age of 65. About 97 percent of cataract surgery patients receive intraocular lens implants, with the annual costs for cataract surgery and associated care in the United States being upwards of $4 billion.
A cataract is any opacity of a patient's lens, whether it is a localized opacity or a diffuse general loss of transparency. To be clinically significant, however, the cataract must cause a significant reduction in visual acuity or a functional impairment. A cataract occurs as a result of aging or secondary to hereditary factors, trauma, inflammation, metabolic or nutritional disorders, or radiation. Age-related cataract conditions are the most common.
In treating a cataract, the surgeon removes material from the lens capsule and replaces it with an intraocular lens (IOL) implant. The typical IOL provides a selected focal length that allows the patient to have fairly good distance vision. Since the lens can no longer accommodate, the patient typically need glasses for reading.
The surgeon selects the power of the IOL based on analysis of refractive characteristics of the patient's eye prior to the surgery. In a significant number or cases, after the patient's eye has healed from the cataract surgery, there is a refractive error that could not be predicted. There remain substantial difficulties in calculating the proper power of an IOL for any particular patient. To solve any unpredicted refractive errors following IOL implantation, the ophthalmologist can perform a repeat surgery to replace the IOL—or the patient can live with the refractive error that may require prescription eyeglasses for both near and distant vision. What is needed is an IOL that carries means for adjusting its power post-implantation, as well as for treating astigmatisms.
The present invention provides an intraocular lens (IOL) that comprises first and second surface portions that are assembled to provide an interior space or chamber within the interior of the lens for allowing fluid flows therein to alter at least one surface portion of the lens to thereby alter optical parameters of the IOL. In an exemplary embodiment, the first and second surface portions extend to the lens body periphery wherein a first portion of the interior chamber extends within the central optic lens element. A peripheral portion of the interior chamber extends about the lens periphery. The invention further provides a microporous or nanoporous body that is intermediate the central and peripheral regions of the interior chamber portions. In one embodiment, the microporous or nanoporous body is capable of cooperating with an external Rf or light source to expose a charge to a charge-carrying fluid within the interior chamber. By this means, fluid flows are induced to alter the optical parameters of the lens.
In another preferred embodiment, the coincident surfaces of the first and second lens portions that bound the interior chamber are configured with projecting shape structures that cooperate with one another and fluid movement to (i) amplify the dynamic range of surface curvature modification and further (ii) to insure that the first and second lens portions are mechanically coupled to allow controlled shape change.
In another preferred embodiment, the lens body is fabricated of first and second structural portions of first and second polymer types. The first structural portion and first polymer type can comprise the substantial part of the optic element, and is a stable, flexible polymer as is known in the art. The second polymer is dimensionally-sensitive to light energy and is thus formed into a second structure that can be controllably changed in shape to move fluids within the interior of the lens or to otherwise directly, or indirectly, deform the first structural portion to alter the optical parameters of the IOL.
In order to better understand the invention and to see how it may be carried out in practice, some preferred embodiments are next described, by way of non-limiting examples only, with reference to the accompanying drawings, in which:
1. Type “A” intraocular lens.
In the embodiment illustrated in
The lens portions 122a and 122b are fabricated of a transparent, flexible material, such as a silicone polymeric material, acrylic polymeric material, hydrogel polymeric material or the like, all of which known in the art of IOL fabrication and allow the lens to be rolled or folded for introduction into the eye through a small incision. As will be described below, the functionality of the lens depends on flexibility or deformability of at least one lens surface, which in the exemplary embodiment of
As can be seen in
In the embodiment of
The haptics or strut members can be polypropylene or like polymeric materials, coupled to the periphery portion 126 and thus extend outwardly to engage the perimeter wall of the capsular sac to maintain the lens in a desired position. The haptics can be glued or welded to the periphery portion 126 or molded along with a portion of the lens. While the configuration of the haptics of the lens shown in
As can be seen in
Of particular interest, a microporous body portion indicated at 160 lies intermediate the first and second chamber portions 155A and 155B. As will be described below, the invention describes means for causing fluid flow from the peripheral chamber portion to the central chamber portion, or vice versa, to alter the shape and optical parameters of the optic portion 125. The terms fluid flow, migration, perfusion and diffusion through the microporous body portion 160 are used interchangeably herein to describe any fluid movement through the microporous portion 160, which also may be described for convenience as porous, microporous, fluid-permeable, fluid-diffusible or fluid-migratable. The microporous body portion 160 can consist of a small section of the body between the first and second chambers, for example, it can extend from 1° to 5° in a radial angle about the lens. Alternatively, the microporous body portion 160 can extend in 360° around the lens between the first and second chamber portions 155A and 155B. As will be described in more detail below, a lens corresponding to the invention may have a plurality of cooperating central and peripheral chambers, in which case each pair of cooperating chambers would be have an intermediate microporous body portion 160. The use of the term “microporous” to describe the fluid-permeable material 160 between the first and second chambers 155A and 155B, and encompasses “nanoporous” materials that allow fluid migration therethrough. More specifically, the cross-sectional dimension of the flow passageways 161 in material 160 for use in the invention range from about 5 nanometers to about 25 microns. More preferably, the cross-sectional dimensions of the flow passageways 161 range from about 100 nanometers to about 5 microns. The microporous material 160 typically is a networked porous polymer wherein the maximum cross-section of a flow passageway therein corresponds to the dimensional ranges described above. The microporous material 160 can be a porous polymer such as a biocompatible polysiloxane, polyurethane, PFTE, polyacrylate, polyamide, polyester, polyolefin, nylon or co-polymers thereof. Many means are known in the art for creating microporous polymers and need not be described further herein. The microporous material 160 also encompasses ordered or nanostructured assembled materials that have pores or channels therein that correspond to the dimensional ranges above. In another preferred embodiment, the microporous material 160 can be a micromachined microchannel material 160 with any suitably shaped channels therein. Such a typically rigid material can be insert-molded into lens. In one such material embodiment, the microchannel structure can be fabricated in silicon by NanoSciences Corporation, Hurley Farms Industrial Park, Bldg. 3, 115 Hurley Rd., Oxford, Conn. 06478. A suitably dimensioned microchannel structure can be fabricated in silicon with high-aspect ratio channel in the range of somewhat less that 1 micron to about 8 microns by NanoSciences Corp. Further, the company's proprietary technology allows for deposition of conductive surfaces within, or at end surfaces of, the microchannels which is useful in some embodiments of the invention disclosed herein.
Referring to
Now turning to
By way of illustration,
2. Type “B” intraocular lens.
3. Type “C” intraocular lens. Referring now to
As shown in
In another embodiment, the IOL of the invention can be simplified by having an interior chamber arrangement with a remote energy source and charge-responsive fluid media M (not shown) that is adapted to cause fluid flow in a single direction, for example, to cause fluid flow into a central optic chamber to increase lens power. Then, the IOL lens power would be implanted with the intention of increasing power post-implantation. In the event that power needed to be decreased, a needle could be inserted to remove fluid.
In another embodiment, the fluid media M in a chamber arrangement of the IOL can carry nanoparticles that are directly responsive to electromagnetic radiation to thereby heat up and expand the fluid. The fluid in one chamber could be selectively heated (e.g., by a optical radiation in the wavelength range of 380 nm to 2000 nm that excites nanoscale chromophore particles or resistively heated elements in or about fluid media M in response to the radiation) wherein the expanded fluid causes fluid flows through a one-way valve within the IOL chamber arrangement to alter the lens shape. Numerous types of one way valves are known in the art and fall within the scope of the invention.
Those skilled in the art will appreciate that the exemplary systems, combinations and descriptions are merely illustrative of the invention as a whole, and that variations in the dimensions and compositions of invention fall within the spirit and scope of the invention. Specific characteristics and features of the invention and its method are described in relation to some figures and not in others, and this is for convenience only. While the principles of the invention have been made clear in the exemplary descriptions and combinations, it will be obvious to those skilled in the art that modifications may be utilized in the practice of the invention, and otherwise, which are particularly adapted to specific environments and operative requirements without departing from the principles of the invention. The appended claims are intended to cover and embrace any and all such modifications, with the limits only of the true purview, spirit and scope of the invention.
This application is a continuation of U.S. application Ser. No. 11/069,136, filed Feb. 28, 2005, now U.S. Pat. No. 7,776,088, which application is a continuation of U.S. application Ser. No. 10/231,433, filed Aug. 29, 2002, now abandoned, which claims benefit of U.S. Provisional Appln. No. 60/316,203, filed Aug. 31, 2001, all of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
4111995 | Nelson | Sep 1978 | A |
4251887 | Anis | Feb 1981 | A |
4253199 | Banko | Mar 1981 | A |
4254509 | Tennant | Mar 1981 | A |
4304895 | Loshaek | Dec 1981 | A |
4373218 | Schachar | Feb 1983 | A |
4409691 | Levy | Oct 1983 | A |
4423809 | Mazzocco | Jan 1984 | A |
4435856 | L'Esperance | Mar 1984 | A |
4466705 | Michelson | Aug 1984 | A |
4490860 | Rainin | Jan 1985 | A |
4494254 | Lopez | Jan 1985 | A |
4512040 | McClure | Apr 1985 | A |
4528311 | Beard et al. | Jul 1985 | A |
4575373 | Johnson | Mar 1986 | A |
4585457 | Kalb | Apr 1986 | A |
4604295 | Humphreys | Aug 1986 | A |
4615701 | Woods | Oct 1986 | A |
4620954 | Singer et al. | Nov 1986 | A |
4685921 | Peyman | Aug 1987 | A |
4685922 | Peyman | Aug 1987 | A |
4693717 | Michelson | Sep 1987 | A |
4720286 | Bailey et al. | Jan 1988 | A |
4731078 | Stoy et al. | Mar 1988 | A |
4731079 | Stoy | Mar 1988 | A |
4731080 | Galin | Mar 1988 | A |
4764423 | Yamaguchi et al. | Aug 1988 | A |
4784485 | Ho | Nov 1988 | A |
4787903 | Grendahl | Nov 1988 | A |
4790847 | Woods | Dec 1988 | A |
4813956 | Gupta | Mar 1989 | A |
4816031 | Pfoff | Mar 1989 | A |
4836201 | Patton et al. | Jun 1989 | A |
4842601 | Smith | Jun 1989 | A |
4848343 | Wallsten et al. | Jul 1989 | A |
4888012 | Horn et al. | Dec 1989 | A |
4892543 | Turely | Jan 1990 | A |
4902293 | Feaster | Feb 1990 | A |
4913536 | Barnea | Apr 1990 | A |
4919151 | Grubbs et al. | Apr 1990 | A |
4932966 | Christie et al. | Jun 1990 | A |
4946469 | Sarfarazi | Aug 1990 | A |
4950289 | Krasner | Aug 1990 | A |
4963148 | Sulc et al. | Oct 1990 | A |
4994082 | Richards et al. | Feb 1991 | A |
4995879 | Dougherty | Feb 1991 | A |
4995880 | Galib | Feb 1991 | A |
5015254 | Greite | May 1991 | A |
5035710 | Nakada et al. | Jul 1991 | A |
5047051 | Cumming | Sep 1991 | A |
5061914 | Busch et al. | Oct 1991 | A |
5066301 | Wiley | Nov 1991 | A |
5078740 | Walman | Jan 1992 | A |
5145884 | Yamamoto et al. | Sep 1992 | A |
5145935 | Hayashi | Sep 1992 | A |
5152789 | Willis | Oct 1992 | A |
5171266 | Wiley et al. | Dec 1992 | A |
5200430 | Federman | Apr 1993 | A |
5201763 | Brady et al. | Apr 1993 | A |
5203788 | Wiley | Apr 1993 | A |
5213579 | Yamada et al. | May 1993 | A |
5224957 | Gasser et al. | Jul 1993 | A |
5235003 | Ward et al. | Aug 1993 | A |
5251993 | Sigourney | Oct 1993 | A |
5275623 | Sarfarazi | Jan 1994 | A |
5275624 | Hara et al. | Jan 1994 | A |
5288293 | O'Donnell, Jr. | Feb 1994 | A |
5290892 | Namdaran et al. | Mar 1994 | A |
5326347 | Cumming | Jul 1994 | A |
5391590 | Gerace et al. | Feb 1995 | A |
5405386 | Rheinish et al. | Apr 1995 | A |
5443506 | Garabet | Aug 1995 | A |
5444106 | Zhou et al. | Aug 1995 | A |
5444135 | Cheradame et al. | Aug 1995 | A |
5476514 | Cumming | Dec 1995 | A |
5489302 | Skottun | Feb 1996 | A |
5496366 | Cumming | Mar 1996 | A |
5506300 | Ward et al. | Apr 1996 | A |
5512609 | Yang | Apr 1996 | A |
5578081 | McDonald | Nov 1996 | A |
5585049 | Grisoni et al. | Dec 1996 | A |
5593436 | Langerman | Jan 1997 | A |
5607472 | Thompson | Mar 1997 | A |
5628795 | Langerman | May 1997 | A |
5633504 | Collins et al. | May 1997 | A |
5665822 | Bitler et al. | Sep 1997 | A |
5674282 | Cumming | Oct 1997 | A |
5676669 | Colvard | Oct 1997 | A |
5697973 | Peyman et al. | Dec 1997 | A |
5702441 | Zhou | Dec 1997 | A |
5774273 | Bornhorst | Jun 1998 | A |
5776191 | Mazzocco | Jul 1998 | A |
5776192 | McDonald | Jul 1998 | A |
5843188 | McDonald | Dec 1998 | A |
5891931 | Leboeuf et al. | Apr 1999 | A |
5928282 | Nigam | Jul 1999 | A |
5964802 | Anello et al. | Oct 1999 | A |
5984962 | Anello et al. | Nov 1999 | A |
6013101 | Israel | Jan 2000 | A |
6015842 | Leboeuf et al. | Jan 2000 | A |
6102539 | Tucker | Aug 2000 | A |
6117171 | Skottun | Sep 2000 | A |
6124980 | Cerbell | Sep 2000 | A |
6139576 | Doyle et al. | Oct 2000 | A |
6160084 | Langer et al. | Dec 2000 | A |
6176878 | Gwon et al. | Jan 2001 | B1 |
6180687 | Hammer et al. | Jan 2001 | B1 |
6188526 | Sasaya et al. | Feb 2001 | B1 |
6190410 | Lamielle et al. | Feb 2001 | B1 |
6195807 | Chou | Mar 2001 | B1 |
6197059 | Cumming | Mar 2001 | B1 |
6217612 | Woods | Apr 2001 | B1 |
6225367 | Chaouk et al. | May 2001 | B1 |
6229641 | Kosaka | May 2001 | B1 |
6299641 | Woods | Oct 2001 | B1 |
6302911 | Hanna | Oct 2001 | B1 |
6322589 | Cumming | Nov 2001 | B1 |
6342073 | Cumming et al. | Jan 2002 | B1 |
6348437 | Avery et al. | Feb 2002 | B1 |
6387126 | Cumming | May 2002 | B1 |
6388043 | Langer et al. | May 2002 | B1 |
6406494 | Laguette et al. | Jun 2002 | B1 |
6413262 | Saishin et al. | Jul 2002 | B2 |
6423094 | Sarfarazi | Jul 2002 | B1 |
6436092 | Peyman | Aug 2002 | B1 |
6443985 | Woods | Sep 2002 | B1 |
6450642 | Jethmalani et al. | Sep 2002 | B1 |
6464725 | Skottun | Oct 2002 | B2 |
6488708 | Sarfarazi | Dec 2002 | B2 |
6493151 | Schachar | Dec 2002 | B2 |
6503276 | Lang et al. | Jan 2003 | B2 |
6517577 | Callahan et al. | Feb 2003 | B1 |
6551354 | Ghazizadeh et al. | Apr 2003 | B1 |
6552860 | Alden | Apr 2003 | B1 |
6554859 | Lang et al. | Apr 2003 | B1 |
6585768 | Hamano et al. | Jul 2003 | B2 |
6589550 | Hodd et al. | Jul 2003 | B1 |
6592621 | Domino | Jul 2003 | B1 |
6599317 | Weinschenk, III et al. | Jul 2003 | B1 |
6601956 | Jean et al. | Aug 2003 | B1 |
6610350 | Suzuki et al. | Aug 2003 | B2 |
6616692 | Glick et al. | Sep 2003 | B1 |
6638304 | Azar | Oct 2003 | B2 |
6638305 | Laguette | Oct 2003 | B2 |
6638306 | Cumming | Oct 2003 | B2 |
6645245 | Preussner | Nov 2003 | B1 |
6645246 | Weinschenk, III et al. | Nov 2003 | B1 |
6656223 | Brady | Dec 2003 | B2 |
6660035 | Lang et al. | Dec 2003 | B1 |
6692525 | Brady et al. | Feb 2004 | B2 |
6695881 | Peng et al. | Feb 2004 | B2 |
6709108 | Levine et al. | Mar 2004 | B2 |
6712848 | Wolf et al. | Mar 2004 | B1 |
6730123 | Klopotek | May 2004 | B1 |
6743388 | Sridharan et al. | Jun 2004 | B2 |
6749632 | Sandstedt et al. | Jun 2004 | B2 |
6749634 | Hanna | Jun 2004 | B2 |
6786934 | Zadno-Azizi et al. | Sep 2004 | B2 |
6818158 | Pham et al. | Nov 2004 | B2 |
6827738 | Willis et al. | Dec 2004 | B2 |
6836374 | Esch et al. | Dec 2004 | B2 |
6860601 | Shadduck | Mar 2005 | B2 |
6878320 | Alderson et al. | Apr 2005 | B1 |
6884261 | Zadno-Azizi et al. | Apr 2005 | B2 |
6899732 | Zadno-Azizi et al. | May 2005 | B2 |
6899850 | Haywood et al. | May 2005 | B2 |
6914247 | Duggan et al. | Jul 2005 | B2 |
6926736 | Peng et al. | Aug 2005 | B2 |
6935743 | Shadduck | Aug 2005 | B2 |
6949093 | Peyman | Sep 2005 | B1 |
6966649 | Shadduck | Nov 2005 | B2 |
6969403 | Peng et al. | Nov 2005 | B2 |
7001374 | Peyman | Feb 2006 | B2 |
7060094 | Shahinpoor et al. | Jun 2006 | B2 |
7068439 | Esch | Jun 2006 | B2 |
7122053 | Esch | Oct 2006 | B2 |
7217288 | Esch et al. | May 2007 | B2 |
7247168 | Esch et al. | Jul 2007 | B2 |
7261737 | Esch et al. | Aug 2007 | B2 |
7264351 | Shadduck | Sep 2007 | B2 |
7276619 | Kunzler et al. | Oct 2007 | B2 |
7278739 | Shadduck | Oct 2007 | B2 |
7438723 | Esch | Oct 2008 | B2 |
7485144 | Esch | Feb 2009 | B2 |
7494505 | Kappelhof et al. | Feb 2009 | B2 |
7763069 | Brady et al. | Jul 2010 | B2 |
7776088 | Shadduck | Aug 2010 | B2 |
7988292 | Neal et al. | Aug 2011 | B2 |
8162927 | Peyman | Apr 2012 | B2 |
20010001836 | Cumming | May 2001 | A1 |
20010016771 | Cumming | Aug 2001 | A1 |
20010039449 | Johnson et al. | Nov 2001 | A1 |
20020046783 | Johnson et al. | Apr 2002 | A1 |
20020055777 | Cumming et al. | May 2002 | A1 |
20020072795 | Green | Jun 2002 | A1 |
20020095212 | Boehm | Jul 2002 | A1 |
20020107568 | Zadno-Azizi et al. | Aug 2002 | A1 |
20020111678 | Zadno-Azizi et al. | Aug 2002 | A1 |
20020116057 | Ting et al. | Aug 2002 | A1 |
20020116058 | Zadno-Azizi et al. | Aug 2002 | A1 |
20020116059 | Zadno-Azizi et al. | Aug 2002 | A1 |
20020116060 | Nguyen et al. | Aug 2002 | A1 |
20020116061 | Zadno-Azizi et al. | Aug 2002 | A1 |
20020133228 | Sarver | Sep 2002 | A1 |
20020161434 | Laguette et al. | Oct 2002 | A1 |
20020161435 | Portney | Oct 2002 | A1 |
20020177896 | Israel | Nov 2002 | A1 |
20020193876 | Lang et al. | Dec 2002 | A1 |
20030003295 | Dreher et al. | Jan 2003 | A1 |
20030004569 | Haefliger | Jan 2003 | A1 |
20030018384 | Valyunin et al. | Jan 2003 | A1 |
20030042176 | Alderson et al. | Mar 2003 | A1 |
20030050695 | Lin et al. | Mar 2003 | A1 |
20030050696 | Cumming | Mar 2003 | A1 |
20030060878 | Shadduck | Mar 2003 | A1 |
20030060881 | Glick et al. | Mar 2003 | A1 |
20030078656 | Nguyen | Apr 2003 | A1 |
20030078657 | Zadno-Azizi et al. | Apr 2003 | A1 |
20030078658 | Zadno-Azizi | Apr 2003 | A1 |
20030083744 | Khoury | May 2003 | A1 |
20030109925 | Ghazizadeh et al. | Jun 2003 | A1 |
20030109926 | Portney | Jun 2003 | A1 |
20030130732 | Sarfarazi | Jul 2003 | A1 |
20030135272 | Brady et al. | Jul 2003 | A1 |
20030149480 | Shadduck | Aug 2003 | A1 |
20030158599 | Brady et al. | Aug 2003 | A1 |
20030171808 | Phillips | Sep 2003 | A1 |
20030183960 | Buazza et al. | Oct 2003 | A1 |
20030187505 | Liao | Oct 2003 | A1 |
20030199977 | Cumming | Oct 2003 | A1 |
20030236376 | Kindt-Larsen et al. | Dec 2003 | A1 |
20040001180 | Epstein | Jan 2004 | A1 |
20040006386 | Valint et al. | Jan 2004 | A1 |
20040006387 | Kelman | Jan 2004 | A1 |
20040008419 | Schachar | Jan 2004 | A1 |
20040015236 | Sarfarazi | Jan 2004 | A1 |
20040039446 | McNicholas | Feb 2004 | A1 |
20040088050 | Norrby et al. | May 2004 | A1 |
20040127984 | Paul et al. | Jul 2004 | A1 |
20040181279 | Nun | Sep 2004 | A1 |
20050021139 | Shadduck | Jan 2005 | A1 |
20050113911 | Peyman | May 2005 | A1 |
20050125000 | Tourrette et al. | Jun 2005 | A1 |
20050165410 | Zadno-Azizi et al. | Jul 2005 | A1 |
20050264756 | Esch | Dec 2005 | A1 |
20060069433 | Nun | Mar 2006 | A1 |
20060158611 | Piers et al. | Jul 2006 | A1 |
20070088433 | Esch et al. | Apr 2007 | A1 |
20070100445 | Shadduck | May 2007 | A1 |
20070106377 | Smith et al. | May 2007 | A1 |
20070203578 | Scholl et al. | Aug 2007 | A1 |
20070213817 | Esch et al. | Sep 2007 | A1 |
20070299487 | Shadduck | Dec 2007 | A1 |
20080015689 | Esch et al. | Jan 2008 | A1 |
20080046074 | Smith et al. | Feb 2008 | A1 |
20080046075 | Esch et al. | Feb 2008 | A1 |
20080200982 | Your | Aug 2008 | A1 |
20080306587 | Your | Dec 2008 | A1 |
20080306588 | Smiley et al. | Dec 2008 | A1 |
20090005865 | Smiley et al. | Jan 2009 | A1 |
20090027661 | Choi et al. | Jan 2009 | A1 |
20090030425 | Smiley et al. | Jan 2009 | A1 |
20090149952 | Shadduck | Jun 2009 | A1 |
20100131058 | Shadduck | May 2010 | A1 |
20100179653 | Argento et al. | Jul 2010 | A1 |
20100228344 | Shadduck | Sep 2010 | A1 |
20100228346 | Esch | Sep 2010 | A1 |
20110208301 | Anvar et al. | Aug 2011 | A1 |
20120078361 | Shadduck | Mar 2012 | A1 |
20120226351 | Peyman | Sep 2012 | A1 |
20130060331 | Shadduck | Mar 2013 | A1 |
20130250239 | Hildebrand et al. | Sep 2013 | A1 |
20130268070 | Esch et al. | Oct 2013 | A1 |
20140249625 | Shadduck | Sep 2014 | A1 |
Number | Date | Country |
---|---|---|
0898972 | Mar 1999 | EP |
2784575 | Apr 2000 | FR |
07-044938 | May 1995 | JP |
8501715 | Feb 1996 | JP |
8224295 | Sep 1996 | JP |
9294754 | Nov 1997 | JP |
10-206609 | Aug 1998 | JP |
10-206609 | Aug 1998 | JP |
11-47168 | Feb 1999 | JP |
11056998 | Mar 1999 | JP |
11276509 | Oct 1999 | JP |
2001-502592 | Feb 2001 | JP |
2003144387 | May 2003 | JP |
2003-524503 | Aug 2003 | JP |
2003530978 | Oct 2003 | JP |
1810052 | Apr 1993 | SU |
WO 9706751 | Feb 1997 | WO |
WO 0041650 | Jul 2000 | WO |
WO 0064655 | Nov 2000 | WO |
WO 0160286 | Aug 2001 | WO |
WO 0189435 | Nov 2001 | WO |
WO 0197742 | Dec 2001 | WO |
WO 02051338 | Feb 2004 | WO |
WO 2004010895 | Feb 2004 | WO |
Entry |
---|
Conlisk, A. T. et al; Mass Transfer and Flow in Electrically Charged Micro-and Nano-channels; Analytical Chemistry, vol. 74; iss. 9; pp. 2139-2150; 2002. |
Gorder, P. F.; Electricity can pump medicine in implanted medical devices; Ohio State Research News; 3 pgs.; May 2, 2002 (printed from internet Aug. 19, 2010). |
Lakes et al., “Dramatically stiffer elastic composite materials due to negative stiffness phase?,” Journal of the Mechanics and Physics of Solids, vol. 50, pp. 979-1009, 2002. |
Lakes, “A broader view of membranes,” Nature, vol. 414, pp. 503-504, Nov. 29, 2001. |
Lendlein et al., “Biodegradable, elastic shape-memory polymers for potential biomedical applications”, Science; vol. 296; pp. 1673-1676; May 31, 2002. |
Lendlein et al., “Shape-memory polymers,” Angew. Chem. Int. Ed.; vol. 41; pp. 2034-2057; 2002. |
Liu et al., “Thermomechanical characterization of a tailored series of shape memory polymers,” Journal of Applied Medical Polymers, vol. 6, No. 2, 2002, pp. 47-52. |
Baughman et al., “Negative poisson's ratios for extreme states fo matter,” Science, vol. 288, pp. 2018-2022, Jun. 16, 2000. |
Dubbelman et al.; The Thickness of the Aging Human Lens Obtained from Corrected Scheimpflug Images; Optometry & Vison Science; vo. 78; iss. 6; pp. 411-416; Jun. 2001. |
Gordon, “Applications of shape memory polyurethanes,” Proceedings of the First Intl Conf. on Shape Memory and Superelastic Tech., Asilomar Conference Center, Pacific Grove, CA, USA, pp. 115-120, 1994. |
Gruber et al.; Exhaustive soxhlet extraction for the complete removal of residual compounds . . . ; Journal of Biomedical Materials Research; vol. 53; No. 5; pp. 445-448; Mar. 2000. |
Jeon et al., “Shape memory and nanostructure in poly(norbornyl-POSS) copolymers,” Polymer International, vol. 49, pp. 453-457, 2000. |
Kim et al., “Polyurethanes having shape memory effects,” Polymer, vol. 37, No. 26, pp. 5781-5793, 1996. |
Lakes et al., “Extreme damping in composite materials with negative-stiffness inclusions,” Nature, vol. 410, pp. 565-567, Mar. 29, 2001. |
Lakes et al., “Microbuckling instability in elastomeric cellular sollids,” J. Materials Science, vol. 28, pp. 4667-4672, 1993. |
Lakes, “Extreme damping in compliant composites with a negative-stiffness phase,” Philosophical Magazine Letters, vol. 81, No. 2, pp. 95-100, 2001. |
Lakes, “Extreme damping in composite materials with a negative stiffness phase,” Physical Review Letters, vol. 86, No. 13, pp. 2897-2900, Mar. 26, 2001. |
Lakes, “Lateral deformations in extreme matter,” Science, vol. 288, pp. 1976, Jun. 2000; 3 pgs. |
Lakes, “Negative poisson's ratio materials,” Science, vol. 238, pp. 551, Oct. 23, 1987. |
Lakes, “No contractile obligations,” Nature, vol. 358, pp. 713-714, 1992. |
Li et al., “Crystallinity and morphology of segmented polyurethanes with different soft-segment length,” Journal of Applied Polymer Science, vol. 62, pp. 631-638, 1996. |
Mather et al., “Strain recovery in POSS hybrid thermoplastics,” Polymer Preprints, vol. 41, No. 1, pp. 528-529, 2000. |
Takahashi et al., “Structure and properties of shape-memory polyurethane block copolymers,” Journal of Applied Polymer Science, vol. 60, pp. 1061-1069, 1996. |
Tobushi et al., “Thermomechanical properties of shape memory polymers of polyurethane series and their applications,” Journal de Physique IV, Colloque C1, vol. 6, pp. 377-384, 1996. |
Vass et al.; Prediction of pseudophakic capsular bag diameter based on biometric variables; J Cataract Refract Surg.; vol. 25; pp. 1376-1381; 1999. |
Wyant et al; “Basic Wavefront Aberration Theory for Optical Metrology,” Applied Optics and Optical Engineering, vol. XI, 1992: pp. 1, 28-39. |
Xu et al., “Basic negative poisson's ratio microstructures by soft lithography,” Advanced Materials, vol. 11, No. 14, 1999, pp. 1186-1189, 1999. |
Esch et al.; U.S. Appl. No. 12/853,892 entitled “Accommodating Intraocular Lens Having Peripherally Actuated Deflectable Surface and Method,” filed Aug. 10, 2010. |
Hildebrand et al.; U.S. Appl. No. 12/872,314 entitled “Lens Capsule Size Estimation,” filed Aug. 31, 2010. |
Scholl et al.; U.S. Appl. No. 13/193,487 entitled “Accommodating Intraocular Lenses,” filed Jul. 28, 2011. |
Smiley et al.; U.S. Appl. No. 13/193,983 entitled “Accommodating Intraocular Lenses,” filed Jul. 29, 2011. |
Smiley et al.; U.S. Appl. No. 13/194,004 entitled “Accommodating Intraocular Lenses,” filed Jul. 29, 2011. |
Hildebrand et al.; U.S. Appl. No. 13/180,427 entitled “Intraocular lens delivery devices and methods of use,” filed Jul. 11, 2011. |
Matthews, Gregory V.; U.S. Appl. No. 13/427,617 entitled “Intraocular Lens Loading Systems and Methods of Use,” filed Mar. 22, 2012. |
Smiley et al.; U.S. Appl. No. 13/672,608 entitled “Accommodating Intraocular Lenses and Methods of Use,” filed Nov. 8, 2012. |
Smiley et al.; U.S. Appl. No. 13/711,552 entitled “Accommodating Intraocular Lenses and Methods of Use,” filled Dec. 11, 2012. |
Lakes; Deformations in extreme matter; Science; perspectives; vol. 288; No. 5473; pp. 1976-1977; Jun. 16, 2000. |
Matthews et al.; U.S. Appl. No. 13/835,876 entitled “Intraocular Lens Delivery Systems and Methods of Use,” filed Mar. 15, 2013. |
Hildebrand et al.; U.S. Appl. No. 14/163,794 entitled “Intraocular Lens Delivery Devices and Methods of Use,” filed Jan. 24, 2014. |
Number | Date | Country | |
---|---|---|---|
20100324671 A1 | Dec 2010 | US |
Number | Date | Country | |
---|---|---|---|
60316203 | Aug 2001 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11069136 | Feb 2005 | US |
Child | 12852733 | US | |
Parent | 10231433 | Aug 2002 | US |
Child | 11069136 | US |